CD73: A Novel Target for Cancer Immunotherapy

The promise of cancer immunotherapy has not been translated into clinical successes, in large part because of tumor-associated immune suppression that blocks effective antitumor immunity. Recent findings show a tumor-induced immunosuppressive mechanism, whereby tumor-derived CD73 functions as an ect...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cancer research (Chicago, Ill.) Ill.), 2010-08, Vol.70 (16), p.6407-6411
1. Verfasser:	Zhang, Bin
Format:	Artikel
Sprache:	eng
Schlagworte:	5'-Nucleotidase - antagonists & inhibitors 5'-Nucleotidase - immunology Animals Antibodies, Monoclonal - immunology Antibodies, Monoclonal - pharmacology Antineoplastic agents Biological and medical sciences Humans Immunotherapy, Adoptive - methods Medical sciences Neoplasms - immunology Neoplasms - therapy Pharmacology. Drug treatments T-Lymphocytes - immunology Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!